Di Fulvio M, Lehman N, Lin X, Lopez I, Gomez-Cambronero J
Department of Physiology & Biophysics, Wright State University School of Medicine, Dayton, OH 45435, USA.
Oncogene. 2006 May 18;25(21):3032-40. doi: 10.1038/sj.onc.1209340.
Our laboratory has recently reported that the enzyme phospholipase D2 (PLD2) exists as a ternary complex with PTP1b and the growth factor receptor bound protein 2 (Grb2). Here, we establish the mechanistic underpinnings of the PLD2/Grb2 association. We have identified residues Y(169) and Y(179) in the PLD2 protein as being essential for the Grb2 interaction. We present evidence indicating that Y(169) and Y(179) are located within two consensus sites in PLD2 that mediate an SH2 interaction with Grb2. This was demonstrated with an SH2-deficient GSTGrb2 R86K mutant that failed to pull-down PLD2 in vitro. In order to elucidate the functions of the two neighboring tyrosines, we created a new class of deletion and point mutants in PLD2. Phenylalanine replacement of Y(169) (PLD2 Y169F) or Y(179) (PLD2 Y179F) reduced Grb2 binding while simultaneous mutation completely abolished it. The role of the two binding sites on PLD2 was found to be functionally nonequivalent: Y(169) serves to modulate the activity of the enzyme, whereas Y(179) regulates total tyrosine phosphorylation of the protein. Interestingly, binding of Grb2 to PLD2 occurs irrespectively of lipase activity, since Grb2 binds to catalytically inactive PLD2 mutants. Finally, PLD2 residues Y(169) and Y(179) are necessary for the recruitment of Sos, but only overexpression of the PLD2 Y179F mutant resulted in increased Ras activity, p44/42(Erk) phosphorylation and enhanced DNA synthesis. Since Y(169) remains able to modulate enzyme activity and is capable of binding to Grb2 in the PLD2 Y179F mutant, we propose that Y(169) is kept under negative regulation by Y(179). When this is released, Y(169) mediates cellular proliferation through the Ras/MAPK pathway.
我们实验室最近报告称,磷脂酶D2(PLD2)作为一种三元复合物,与蛋白酪氨酸磷酸酶1b(PTP1b)及生长因子受体结合蛋白2(Grb2)一同存在。在此,我们确立了PLD2与Grb2结合的作用机制。我们已确定PLD2蛋白中的酪氨酸(Y)残基Y(169)和Y(179)对与Grb2的相互作用至关重要。我们提供的证据表明,Y(169)和Y(179)位于PLD2的两个共有位点内,介导与Grb2的SH2相互作用。这通过一个SH2缺陷型的GSTGrb2 R86K突变体得以证明,该突变体在体外无法下拉PLD2。为了阐明这两个相邻酪氨酸的功能,我们构建了一类新的PLD2缺失和点突变体。用苯丙氨酸取代Y(169)(PLD2 Y169F)或Y(179)(PLD2 Y179F)会降低Grb2的结合,而同时突变则会完全消除这种结合。发现PLD2上的两个结合位点在功能上并不等同:Y(169)用于调节酶的活性,而Y(179)则调节该蛋白的总酪氨酸磷酸化。有趣的是,Grb2与PLD2的结合与脂肪酶活性无关,因为Grb2可与催化无活性的PLD2突变体结合。最后,PLD2的Y(169)和Y(179)残基对于Sos的募集是必需的,但只有PLD2 Y179F突变体的过表达会导致Ras活性增加、p44/42(Erk)磷酸化增强以及DNA合成增加。由于在PLD2 Y179F突变体中Y(169)仍能够调节酶活性并且能够与Grb2结合,我们提出Y(169)受到Y(179)的负调控。当这种负调控解除时,Y(169)通过Ras/丝裂原活化蛋白激酶(MAPK)途径介导细胞增殖。